Estrosas, Baby Girl .

HRN: 23-70-92  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2023
MUPIROCIN 2%, 15G (TUBE)
09/12/2023
09/18/2023
TOPICAL OU
Thinly
Bid
Folliculitis
Waiting Final Action 
09/14/2023
OXACILLIN 500MG (VIAL)
09/14/2023
09/20/2023
IV
250mg
Q6h
Folliculitis
Waiting Final Action 
09/14/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/14/2023
09/20/2023
PO
4ml
Q8
AGE With Moderate Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: